Recruiting NA Cancer (Colon Cancer, Breast Cancer, Lymphoma, Chronic Lymphoma Leukemia, Multiple Myeloma)

Prevention study for Cancer (Colon Cancer, Breast Cancer, Lymphoma, Chronic Lymphoma Leukemia,...

Official title Cardiovascular Prevention Strategies in Elderly Patients With Cancer (CARTIER Clinical Trial)

ClinicalTrials.gov ID: NCT03711110

What this study is testing

What it's testing
The CARTIER study is a randomized, multicenter, open-label clinical trial comparing, in elderly patients with cancer under anti-tumoral treatment, two different cardiotoxicity prevention strategies: primary (intensive cardiovascular monitoring focused on prevention and early diagnosis and treatment of cardiotoxicity based in cardio-onco-hematology teams involved in cancer patient care) vs. secondary (current clinical practice where intensive cardiovascular monitoring is not routinely performed and cardiotoxicity patient care is based on the onco-hematologist criteria).
  • Which group you join is decided by chance.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 65 and older

You may be able to join if

  • \> 65 years old
  • Expected survival \>1 year
  • Colon cancer, breast cancer, lymphoma, chronic lymphoma leukemia, chronic myeloid leukemia, myeloma
  • Signature on the informed consent

You likely can't join if

  • Patients included in clinical trials will be excluded if they interfere with the CARTIER follow-up protocol. If they do not interfere they can be...
  • Patients who had received previous potentially cardiotoxic anticancer treatment

The study team makes the final eligibility decision.

Where it's taking place

  • Santiago de Compostela, A Coruña, Spain
  • Galdakao, Vizcaya, Spain
  • Barcelona, Spain
  • Córdoba, Spain
  • Madrid, Spain
  • Málaga, Spain
  • Salamanca, Spain
  • Seville, Spain
  • Valladolid, Spain

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 65 years and older. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Santiago de Compostela, A Coruña, Spain; Galdakao, Vizcaya, Spain; Barcelona, Spain; Córdoba, Spain; Madrid, Spain; Málaga, Spain and 3 more location(s). Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.